JPMorgan Sues Indonesia’s Biggest Drug Maker Over Dollar Hedge
>> 
2009-01-15 12:54:08.907 GMT
>>
>>
>> By James 
Lumley
>>      Jan. 15 (Bloomberg) -- JPMorgan Chase & Co.., the 
second-
>> largest U.S. bank by assets, sued Indonesia’s biggest 
drugmaker,
>> seeking $19.2 million over allegations the company 
reneged on a
>> currency-hedging agreement.
>>      PT Kalbe 
Farma refused to honor two exchange-rate derivative
>> contracts last 
year and JPMorgan is seeking payment of an early
>> termination fee, 
the bank said in a lawsuit filed in London in
>> September and released 
in part by the court this week.
>>      Kalbe, a client of JPMorgan’s 
credit and rates markets
>> division, hedged against currency 
fluctuations by exchanging
>> rupiahs for dollars until June. Kalbe’s 
products are made from
>> imported materials bought with U.S. dollars 
and sold for
>> Indonesian rupiahs, according to the 
filing.
>>      The Jakarta-based company stopped paying in June and 
sent a
>> letter to JPMorgan stating their contract was no longer 
legally
>> binding and alleging negligence, according to the 
filing.
>> JPMorgan, based in New York, sued in London’s High Court 
to
>> enforce the deal.
>>      “JPM performed its obligations 
under the transactions by
>> making payments to Kalbe when due,” the 
bank said in its filing.
>> “Kalbe accepted the payments,” the filing 
said. “and at no
>> time prior to 27 June 2008 did it indicate to JPM 
that it
>> believed it had not entered into binding 
contracts.”
>>      Justian Sumardi, Kalbe’s corporate secretary, 
couldn’t be
>> reached for comment at his office or on his mobile 
phone. David
>> Wells, a JPMorgan spokesman, declined to 
comment.
>>
>> For Related News:
>> UK Legal News: NI 
ELEGAL <GO>
>> Top Legal News: TLAW 
<GO>
>>
>> --With reporting by Arijit Ghosh in Jakarta. 
Editor: Jeff
>> St.Onge, Anthony Aarons.
>>
>> To 
contact the reporter on this story:
>> James Lumley in London at +44 20 
7073-3684 or
>> jluml...@bloomberg.net.
>>
>> 
To contact the editor responsible for this story:
>> Anthony Aarons at 
+44-20-7673-2227 or
>> aaar...@bloomberg.net.



      

Kirim email ke